AI Enabled Trials in Neurodegeneration: London Summit Insights
LifeArc and the DEMON Network share talks from the London Summit on AI Enabled Trials in Neurodegeneration, covering AI, trial design and remote trials.
LifeArc and the DEMON Network share talks from the London Summit on AI Enabled Trials in Neurodegeneration, covering AI, trial design and remote trials.
Dr Marcella Montagnese develops AI neuroimaging tools at Cambridge to map brain ageing and detect changes linked to cognitive decline and dementia earlier.
Dr Emma Elliott is a Research Associate at The University of Manchester, studying cognitive impairment and neuropsychology in dementia research.
Dr Carla Abdelnour is a neurologist at Hospital de la Santa Creu i Sant Pau researching biomarkers and personalised care in LBD and Alzheimer’s disease.
Dr Vanessa Young is a postdoctoral fellow at UT Health San Antonio, studying sleep, stress biology and Alzheimer’s risk in underserved communities.
Professor Carmela Tartaglia is a Toronto neurologist researching neurodegeneration and biomarkers to improve diagnosis and precision care.
In this podcast, Dr Niranjan Bose, Jonathan Hoover and Dr Kexin Huang on the Alzheimer’s Insights AI Prize and what agentic AI means for dementia research.
Alzheimer Europe Research Insights, webinar recordings on data sharing, collaboration and key dementia research developments across Europe.
Professor Christian Benedict is Professor of Pharmacology at Uppsala University, researching how sleep affects the brain and dementia risk.
Alzheimer’s Research UK invests a record £9.5m in 25 dementia research projects, supporting new ideas, better diagnosis and future treatments.
Dr Clare Ellis Smith is a Senior Lecturer at King’s College London researching dementia palliative care and person centred outcomes for families and carers.
The Hidden REF 2026 is open. It celebrates the data, tools and people dementia research relies on but the REF overlooks. Entries close 13 Sept.